Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

The arginine deiminase operon is responsible for a fitness trade-off in extended-spectrum β-lactamase encoding strains of Escherichia coli.

Billard-Pomares T, Clermont O, Castellanos M, Magdoud F, Royer G, Condamine B, Fouteau S, Barbe V, Roche D, Cruveiller S, Médigue C, Pognard D, Glodt J, Dion S, Rigal O, Picard B, Denamur E, Branger C.

Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00635-19. doi: 10.1128/AAC.00635-19. [Epub ahead of print]

PMID:
31138573
2.

Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) Myopathy Misdiagnosed as Polymyositis.

Barp A, Bellance R, Malfatti E, Rigal O, Acquaviva-Bourdain C, Laforet P.

J Clin Rheumatol. 2019 Feb 19. doi: 10.1097/RHU.0000000000001000. [Epub ahead of print] No abstract available.

PMID:
30801335
3.

Myopathy with MTCYB mutation mimicking Multiple Acyl-CoA Dehydrogenase Deficiency.

Kaphan E, Bou Ali H, Gastaldi M, Acquaviva C, Vianey-Saban C, Rouzier C, Fragaki K, Bannwarth S, Paquis-Flucklinger V, Romero N, Behin A, Lombès A, Jardel C, Rigal O, Laforêt P.

Rev Neurol (Paris). 2018 Dec;174(10):731-735. doi: 10.1016/j.neurol.2018.03.014. Epub 2018 Oct 11.

PMID:
30318261
4.

Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer.

Lange M, Heutte N, Noal S, Rigal O, Kurtz JE, Lévy C, Allouache D, Rieux C, Lefel J, Clarisse B, Leconte A, Veyret C, Barthélémy P, Longato N, Tron L, Castel H, Eustache F, Giffard B, Joly F.

Oncologist. 2019 Jan;24(1):62-68. doi: 10.1634/theoncologist.2017-0570. Epub 2018 Jun 22.

PMID:
29934409
5.

Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.

Ruiz M, Labarthe F, Fortier A, Bouchard B, Thompson Legault J, Bolduc V, Rigal O, Chen J, Ducharme A, Crawford PA, Tardif JC, Des Rosiers C.

Am J Physiol Heart Circ Physiol. 2017 Oct 1;313(4):H768-H781. doi: 10.1152/ajpheart.00820.2016. Epub 2017 Jul 14.

6.

Dopamine and serotonin levels in cerebrospinal fluid during episodes of Kleine-Levin syndrome.

Maranci JB, Roze E, Benoist JF, Mochel F, Rigal O, Arnulf I.

Sleep Med. 2017 Aug;36:184-185. doi: 10.1016/j.sleep.2017.05.001. Epub 2017 May 27. No abstract available.

PMID:
28629702
7.

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor.

Clatot F, Perdrix A, Augusto L, Beaussire L, Delacour J, Calbrix C, Sefrioui D, Viailly PJ, Bubenheim M, Moldovan C, Alexandru C, Tennevet I, Rigal O, Guillemet C, Leheurteur M, Gouérant S, Petrau C, Théry JC, Picquenot JM, Veyret C, Frébourg T, Jardin F, Sarafan-Vasseur N, Di Fiore F.

Oncotarget. 2016 Nov 15;7(46):74448-74459. doi: 10.18632/oncotarget.12950.

8.

Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment.

Lange M, Heutte N, Rigal O, Noal S, Kurtz JE, Lévy C, Allouache D, Rieux C, Lefel J, Clarisse B, Veyret C, Barthélémy P, Longato N, Castel H, Eustache F, Giffard B, Joly F.

Oncologist. 2016 Nov;21(11):1337-1348. doi: 10.1634/theoncologist.2016-0014. Epub 2016 Jul 29.

9.

Riboflavin-Responsive and -Non-responsive Mutations in FAD Synthase Cause Multiple Acyl-CoA Dehydrogenase and Combined Respiratory-Chain Deficiency.

Olsen RKJ, Koňaříková E, Giancaspero TA, Mosegaard S, Boczonadi V, Mataković L, Veauville-Merllié A, Terrile C, Schwarzmayr T, Haack TB, Auranen M, Leone P, Galluccio M, Imbard A, Gutierrez-Rios P, Palmfeldt J, Graf E, Vianey-Saban C, Oppenheim M, Schiff M, Pichard S, Rigal O, Pyle A, Chinnery PF, Konstantopoulou V, Möslinger D, Feichtinger RG, Talim B, Topaloglu H, Coskun T, Gucer S, Botta A, Pegoraro E, Malena A, Vergani L, Mazzà D, Zollino M, Ghezzi D, Acquaviva C, Tyni T, Boneh A, Meitinger T, Strom TM, Gregersen N, Mayr JA, Horvath R, Barile M, Prokisch H.

Am J Hum Genet. 2016 Jun 2;98(6):1130-1145. doi: 10.1016/j.ajhg.2016.04.006.

10.

Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease.

Béhin A, Acquaviva-Bourdain C, Souvannanorath S, Streichenberger N, Attarian S, Bassez G, Brivet M, Fouilhoux A, Labarre-Villa A, Laquerrière A, Pérard L, Kaminsky P, Pouget J, Rigal O, Vanhulle C, Eymard B, Vianey-Saban C, Laforêt P.

Rev Neurol (Paris). 2016 Mar;172(3):231-41. doi: 10.1016/j.neurol.2015.11.008. Epub 2016 Mar 30.

PMID:
27038534
11.

SLC25A32 Mutations and Riboflavin-Responsive Exercise Intolerance.

Schiff M, Veauville-Merllié A, Su CH, Tzagoloff A, Rak M, Ogier de Baulny H, Boutron A, Smedts-Walters H, Romero NB, Rigal O, Rustin P, Vianey-Saban C, Acquaviva-Bourdain C.

N Engl J Med. 2016 Feb 25;374(8):795-7. doi: 10.1056/NEJMc1513610. No abstract available.

12.

Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.

Joly F, Giffard B, Rigal O, De Ruiter MB, Small BJ, Dubois M, LeFel J, Schagen SB, Ahles TA, Wefel JS, Vardy JL, Pancré V, Lange M, Castel H.

J Pain Symptom Manage. 2015 Dec;50(6):830-41. doi: 10.1016/j.jpainsymman.2015.06.019. Epub 2015 Sep 5. Review.

PMID:
26344551
13.

Port catheter versus peripherally inserted central catheter for postoperative chemotherapy in early breast cancer: a retrospective analysis of 448 patients.

Lefebvre L, Noyon E, Georgescu D, Proust V, Alexandru C, Leheurteur M, Thery JC, Savary L, Rigal O, Di Fiore F, Veyret C, Clatot F.

Support Care Cancer. 2016 Mar;24(3):1397-403. doi: 10.1007/s00520-015-2901-8. Epub 2015 Sep 5.

PMID:
26342484
14.

[Nutritional management of patients with head and neck cancer treated with radiation].

Thureau S, Lefebvre L, Dandoy S, Guérault F, Ebran M, Lebreton M, Veresezan O, Rigal O, Clatot F.

Cancer Radiother. 2015 Oct;19(6-7):552-5. doi: 10.1016/j.canrad.2015.07.153. Epub 2015 Aug 28. French.

PMID:
26321684
15.

Diagnostic Algorithm for Glycogenoses and Myoadenylate Deaminase Deficiency Based on Exercise Testing Parameters: A Prospective Study.

Rannou F, Uguen A, Scotet V, Le Maréchal C, Rigal O, Marcorelles P, Gobin E, Carré JL, Zagnoli F, Giroux-Metges MA.

PLoS One. 2015 Jul 24;10(7):e0132972. doi: 10.1371/journal.pone.0132972. eCollection 2015.

16.

Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer.

Sefrioui D, Perdrix A, Sarafan-Vasseur N, Dolfus C, Dujon A, Picquenot JM, Delacour J, Cornic M, Bohers E, Leheurteur M, Rigal O, Tennevet I, Thery JC, Alexandru C, Guillemet C, Moldovan C, Veyret C, Frebourg T, Di Fiore F, Clatot F.

Int J Cancer. 2015 Nov 15;137(10):2513-9. doi: 10.1002/ijc.29612. Epub 2015 Jun 11.

17.

Interactions between genotype and environment drive the metabolic phenotype within Escherichia coli isolates.

Sabarly V, Aubron C, Glodt J, Balliau T, Langella O, Chevret D, Rigal O, Bourgais A, Picard B, de Vienne D, Denamur E, Bouvet O, Dillmann C.

Environ Microbiol. 2016 Jan;18(1):100-17. doi: 10.1111/1462-2920.12855. Epub 2015 May 11.

PMID:
25808978
18.

Baseline cognitive functions among elderly patients with localised breast cancer.

Lange M, Giffard B, Noal S, Rigal O, Kurtz JE, Heutte N, Lévy C, Allouache D, Rieux C, Le Fel J, Daireaux A, Clarisse B, Veyret C, Barthélémy P, Longato N, Eustache F, Joly F.

Eur J Cancer. 2014 Sep;50(13):2181-9. doi: 10.1016/j.ejca.2014.05.026. Epub 2014 Jun 20.

19.

Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists.

Lange M, Rigal O, Clarisse B, Giffard B, Sevin E, Barillet M, Eustache F, Joly F.

Cancer Treat Rev. 2014 Jul;40(6):810-7. doi: 10.1016/j.ctrv.2014.03.003. Epub 2014 Mar 20. Review.

PMID:
24713425
20.

Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer.

Di Fiore A, Lecleire S, Gangloff A, Rigal O, Benyoucef A, Blondin V, Sefrioui D, Quiesse M, Iwanicki-Caron I, Michel P, Di Fiore F.

Dig Liver Dis. 2014 Mar;46(3):270-5. doi: 10.1016/j.dld.2013.10.016. Epub 2014 Jan 14.

PMID:
24439424
21.

A higher body mass index and fat mass are factors predictive of docetaxel dose intensity.

Gouérant S, Leheurteur M, Chaker M, Modzelewski R, Rigal O, Veyret C, Lauridant G, Clatot F.

Anticancer Res. 2013 Dec;33(12):5655-62.

PMID:
24324113
22.

Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: final results of the DOGMES multicentre GINECO trial.

Falandry C, Brain E, Bonnefoy M, Mefti F, Jovenin N, Rigal O, Guillem O, El Kouri C, Uwer L, Abadie-Lacourtoisie S, Cretin J, Jacquin JP, Paraiso D, Freyer G.

Eur J Cancer. 2013 Sep;49(13):2806-14. doi: 10.1016/j.ejca.2013.04.027. Epub 2013 Jun 1.

PMID:
23735702
23.

Methylation metabolites in amniotic fluid depend on gestational age.

Imbard A, Blom HJ, Schlemmer D, Barto R, Czerkiewicz I, Rigal O, Muller F, Benoist JF.

Prenat Diagn. 2013 Sep;33(9):848-55. doi: 10.1002/pd.4142. Epub 2013 May 31.

PMID:
23613283
24.

[Impact of cancer treatments on cognitive functions: the patients' view, their expectation and their interest in participating to cognitive rehabilitation workshops].

Le Fel J, Daireaux A, Vandenbosshe S, Heutte N, Rigal O, Rovira K, Joly F, Roy V.

Bull Cancer. 2013 Mar;100(3):223-9. doi: 10.1684/bdc.2013.1710. French.

PMID:
23501351
25.

Phosphoethanolamine normal range in pediatric urines for hypophosphatasia screening.

Imbard A, Alberti C, Armoogum-Boizeau P, Ottolenghi C, Josserand E, Rigal O, Benoist JF.

Clin Chem Lab Med. 2012 Dec;50(12):2231-3. No abstract available.

PMID:
23093084
26.

How can cobalamin injections be spaced in long-term therapy for inborn errors of vitamin B(12) absorption?

Boina Abdallah A, Ogier de Baulny H, Kozyraki R, Passemard S, Fenneteau O, Lebon S, Rigal O, Mesples B, Yacouben K, Giraudier S, Benoist JF, Schiff M.

Mol Genet Metab. 2012 Sep;107(1-2):66-71. doi: 10.1016/j.ymgme.2012.07.007. Epub 2012 Jul 20.

PMID:
22854512
27.

French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3.

Joly F, Lange M, Rigal O, Correia H, Giffard B, Beaumont JL, Clisant S, Wagner L.

Support Care Cancer. 2012 Dec;20(12):3297-305. doi: 10.1007/s00520-012-1439-2. Epub 2012 May 2.

PMID:
22549504
28.

Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib.

Di Fiore F, Rigal O, Ménager C, Michel P, Pfister C.

Br J Cancer. 2011 Dec 6;105(12):1811-3. doi: 10.1038/bjc.2011.507. Epub 2011 Nov 17.

29.

Measurement of free and total sialic acid by isotopic dilution liquid chromatography tandem mass spectrometry method.

Tebani A, Schlemmer D, Imbard A, Rigal O, Porquet D, Benoist JF.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Dec 1;879(31):3694-9. doi: 10.1016/j.jchromb.2011.10.009. Epub 2011 Oct 13.

PMID:
22035979
30.

Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency.

Boutron A, Acquaviva C, Vianey-Saban C, de Lonlay P, de Baulny HO, Guffon N, Dobbelaere D, Feillet F, Labarthe F, Lamireau D, Cano A, de Villemeur TB, Munnich A, Saudubray JM, Rabier D, Rigal O, Brivet M.

Mol Genet Metab. 2011 Aug;103(4):341-8. doi: 10.1016/j.ymgme.2011.04.006. Epub 2011 Apr 19.

PMID:
21549624
31.

Fatal heart failure associated with CoQ10 and multiple OXPHOS deficiency in a child with propionic acidemia.

Fragaki K, Cano A, Benoist JF, Rigal O, Chaussenot A, Rouzier C, Bannwarth S, Caruba C, Chabrol B, Paquis-Flucklinger V.

Mitochondrion. 2011 May;11(3):533-6. doi: 10.1016/j.mito.2011.02.002. Epub 2011 Feb 15.

PMID:
21329767
32.

Subacute myopathy in a mature patient due to multiple acyl-coenzyme A dehydrogenase deficiency.

Kaminsky P, Acquaviva-Bourdain C, Jonas J, Pruna L, Chaloub GE, Rigal O, Grignon Y, Vianey-Saban C.

Muscle Nerve. 2011 Mar;43(3):444-6. doi: 10.1002/mus.21881.

PMID:
21321959
33.

Cognitive dysfunction and cancer: which consequences in terms of disease management?

Joly F, Rigal O, Noal S, Giffard B.

Psychooncology. 2011 Dec;20(12):1251-8. doi: 10.1002/pon.1903. Epub 2011 Jan 21. Review.

PMID:
21254307
34.

Post-mortem MRI reveals CPT2 deficiency after sudden infant death.

Bouchireb K, Teychene AM, Rigal O, de Lonlay P, Valayannopoulos V, Gaudelus J, Sellier N, Bonnefont JP, Brivet M, de Pontual L.

Eur J Pediatr. 2010 Dec;169(12):1561-3. doi: 10.1007/s00431-010-1261-0. Epub 2010 Jul 27.

PMID:
20661589
35.

Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy.

Sacconi S, Trevisson E, Salviati L, Aymé S, Rigal O, Redondo AG, Mancuso M, Siciliano G, Tonin P, Angelini C, Auré K, Lombès A, Desnuelle C.

Neuromuscul Disord. 2010 Jan;20(1):44-8. doi: 10.1016/j.nmd.2009.10.014. Epub 2009 Nov 27.

PMID:
19945282
36.

[Multiple acyl-CoA dehydrogenase deficiency (MADD): a curable cause of genetic muscular lipidosis].

Maillart E, Acquaviva-Bourdain C, Rigal O, Brivet M, Jardel C, Lombès A, Eymard B, Vianey-Saban C, Laforêt P.

Rev Neurol (Paris). 2010 Mar;166(3):289-94. doi: 10.1016/j.neurol.2009.05.009. Epub 2009 Jul 9. French.

PMID:
19592060
37.

[Pneumocystis pneumonia in two breast cancer patients treated with docetaxel: an unusual adverse event of chemotherapy].

Philippin-Lauridant G, Clatot F, Rigal O, Laberge-Le-Couteulx S, Guillemet C, Blot E.

Rev Med Interne. 2010 Apr;31(4):e1-3. doi: 10.1016/j.revmed.2009.03.354. Epub 2009 Apr 29. French.

PMID:
19406536
38.

Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.

Laforêt P, Acquaviva-Bourdain C, Rigal O, Brivet M, Penisson-Besnier I, Chabrol B, Chaigne D, Boespflug-Tanguy O, Laroche C, Bedat-Millet AL, Behin A, Delevaux I, Lombès A, Andresen BS, Eymard B, Vianey-Saban C.

Neuromuscul Disord. 2009 May;19(5):324-9. doi: 10.1016/j.nmd.2009.02.007. Epub 2009 Mar 26.

PMID:
19327992
39.

Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis.

Tougeron D, Di Fiore F, Hamidou H, Rigal O, Paillot B, Michel P.

Oncology. 2007;73(5-6):328-34. doi: 10.1159/000134476. Epub 2008 May 23.

PMID:
18497505
40.

[Comorbidity and dementia].

Chassagne P, Idrissi-Kassimy F, Rigal O.

Psychol Neuropsychiatr Vieil. 2008 Mar;6(1):43-8. doi: 10.1684/pnv.2008.0111. Review. French.

41.

Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency.

Aeby A, Sznajer Y, Cavé H, Rebuffat E, Van Coster R, Rigal O, Van Bogaert P.

J Inherit Metab Dis. 2007 Oct;30(5):827. Epub 2007 Aug 20.

PMID:
17703371
42.

Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer.

Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, Ducrotté P, Lerebours E, Michel P.

Am J Gastroenterol. 2007 Nov;102(11):2557-63. Epub 2006 Aug 4.

PMID:
17680847
43.

Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer.

Di Fiore F, Lecleire S, Galais MP, Rigal O, Vié B, David I, Hamidou H, Paillot B, Jacob JH, Michel P.

Gastroenterol Clin Biol. 2006 Jun-Jul;30(6-7):845-51.

44.

Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.

Di Fiore F, Lecleire S, Rigal O, Galais MP, Ben Soussan E, David I, Paillot B, Jacob JH, Michel P.

World J Gastroenterol. 2006 Jul 14;12(26):4185-90.

45.

Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy.

Mok E, Eléouet-Da Violante C, Daubrosse C, Gottrand F, Rigal O, Fontan JE, Cuisset JM, Guilhot J, Hankard R.

Am J Clin Nutr. 2006 Apr;83(4):823-8.

PMID:
16600934
46.

Detection of 28 neurotransmitters and related compounds in biological fluids by liquid chromatography/tandem mass spectrometry.

Bourcier S, Benoist JF, Clerc F, Rigal O, Taghi M, Hoppilliard Y.

Rapid Commun Mass Spectrom. 2006;20(9):1405-21.

PMID:
16572467
47.

Goitre and iodine deficiency in Afghanistan: a case-control study.

Oberlin O, Plantin-Carrenard E, Rigal O, Wilkinson C.

Br J Nutr. 2006 Jan;95(1):196-203.

PMID:
16441934
48.

Characterization of insulin secretion and resistance in type 2 diabetes of adolescents.

Druet C, Tubiana-Rufi N, Chevenne D, Rigal O, Polak M, Levy-Marchal C.

J Clin Endocrinol Metab. 2006 Feb;91(2):401-4. Epub 2005 Nov 15.

PMID:
16291705
49.

In situ lipolytic regulation in subjects born small for gestational age.

Boiko J, Jaquet D, Chevenne D, Rigal O, Czernichow P, Lévy-Marchal C.

Int J Obes (Lond). 2005 Jun;29(6):565-70.

PMID:
15889114
50.

Methylmalonic and propionic acidaemias: management and outcome.

de Baulny HO, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM.

J Inherit Metab Dis. 2005;28(3):415-23. Review.

PMID:
15868474

Supplemental Content

Support Center